GlassScriptPhysician profile
Kathleen Gee
NPI 1386852226
$4,654.60
in general payments reported to CMS, 2019-2025
16 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $929 · 2021: $324 · 2022: $395 · 2023: $465 · 2024: $460 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $1,984.74 | 2019-2022 | |
| Abbvie INC. | $705.17 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $358.82 | 2019-2025 | |
| Alcon Vision LLC | $351.02 | 2019-2025 | Rocklatan, Clareon, Argos |
| Allergan, INC. | $263.17 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $218.78 | 2022-2025 | Vyzulta, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.96 | 2019-2020 | |
| Thea Pharma INC. | $146.24 | 2022-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $143.83 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $89.76 | 2019-2021 | |
| Oyster Point Pharma, INC. | $72.23 | 2022-2024 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $42.87 | 2019-2021 | |
| Rxsight INC | $40.83 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Ocular Therapeutix, INC. | $40.27 | 2019-2025 | Dextenza |
| Harrow Eye, LLC | $29.03 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $13.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Gee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.